Rosetta Genomics rosettagenomics.com


Public list: Digital Health (5963) Genomics (546)

Rosetta Genomics (NASDAQ: ROSG) is a molecular diagnostics company advancing microRNA-based diagnostics discovered and developed through its proprietary microRNAs and platform technologies. Backed by a strong IP portfolio, Rosetta Genomics' scientists have developed proprietary platform technologies for the identification, extraction, quantification, and analysis of microRNAs from a wide range of sample types. These technologies enable the identification and advancement of multiple diagnostic pr...Show all

Rosetta Genomics (NASDAQ: ROSG) is a molecular diagnostics company advancing microRNA-based diagnostics discovered and developed through its proprietary microRNAs and platform technologies. Backed by a strong IP portfolio, Rosetta Genomics' scientist...Show all

Company (Dead / Inactive)

Phone: 732-246-9900

Fax: 732-246-9988

10 Plaut St.

Rehovot, 76706
Israel

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Rosetta Genomics $0M Jun 3, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Rosetta Genomics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
GlenRock IsraelPrivate EquityHerzliya, IsraelOther Investors
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Nucleic acids related to mir-29b-1-5p and uses thereof May 04, 2017 Mar 20, 2018 Patent
Methods for lung cancer classification Mar 26, 2012 Mar 13, 2018 Patent
Nucleic acid compositions related to mir-138-1-3p and uses thereof May 04, 2017 Feb 13, 2018 Patent
Targeting micrornas for the treatment of liver cancer Oct 26, 2016 Dec 19, 2017 Patent
Untitled Jan 08, 2015 Dec 05, 2017 Patent
See all 76 patents